ROVI announces the agreement with Hikma to distribute and market its Enoxaparin biosimilar


No votes yet
 
Relacionados
ROVI Pharma Industrial Services S.A.U. ha sido beneficiaria de una ayuda para la eficiencia energética del sector industrial de la...
1 min
15/09/2020